Impact Partnership Wealth’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Buy
+385
New +$217K 0.02% 414
2025
Q1
Sell
-974
Closed -$344K 344
2024
Q4
$344K Buy
974
+265
+37% +$97.4K 0.07% 182
2024
Q3
$254K Buy
+709
New +$239K 0.06% 200
2024
Q2
Sell
-2
Closed -$459 655
2024
Q1
$459 Sell
2
-479
-100% -$108K ﹤0.01% 656
2023
Q4
$106K Buy
+481
New +$111K 0.04% 237

Other funds holding UTHR

Impact Partnership Wealth's UTHR Position: Q2 2026 in Review

Impact Partnership Wealth opened a new position in United Therapeutics (UTHR) in Q2 2026: 385 shares worth $209K. The stake represents 0.02% of the portfolio and ranks #414 among its holdings. This is a return to the name: Impact Partnership Wealth previously reported a position in UTHR as recently as Q4 2024.

Impact Partnership Wealth first reported a position in UTHR in Q4 2023 and has held it in 5 quarters since. The position peaked at $344K in Q4 2024. 883 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Impact Partnership Wealth held 385 shares of United Therapeutics worth $209K as of Q2 2026.
  • United Therapeutics was a new Impact Partnership Wealth position in Q2 2026.
  • United Therapeutics made up 0.02% of Impact Partnership Wealth's portfolio in Q2 2026, its #414 holding.
  • Impact Partnership Wealth first reported a position in United Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • Impact Partnership Wealth's United Therapeutics position peaked at $344K in Q4 2024.
  • 883 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Impact Partnership Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.